IMNM’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect?

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price increase of 106.64%. However, over the past six months, we’ve seen a weaker performance of 173.30%. The price of IMNM leaped by -8.64% over the last 30 days. And in the last five days, it has fallen by -9.09%.

The stock market performance of Immunome Inc has been very steady. Over the last year, the company’s stock hit its highest at $30.96 on 03/07/24, while the lowest price during the same time frame was $4.44, recorded on 05/01/23.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


52-week price history of IMNM Stock

The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Immunome Inc’s current trading price is -28.58% away from its 52-week high, while its distance from the 52-week low is 397.97%. The stock’s price range for this period has been between $4.44 and $30.96. The Healthcare sector company’s shares saw a trading volume of about 1.17 million for the day, which was higher than the average daily volume of 0.7 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Immunome Inc (IMNM) has experienced a quarterly rise of 106.06% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.23B and boasts a workforce of 55 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 15.73, with a change in price of +13.36. Similarly, Immunome Inc recorded 514,873 in trading volume during the last 100 days, posting a change of +152.69%.

IMNM’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for IMNM stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.

IMNM Stock Stochastic Average

As of today, the raw stochastic average of Immunome Inc over the past 50 days is 51.31%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 5.40%. Additionally, the Stochastic %K and %D values for the company were 23.72% and 32.66%, respectively, over the past 20 days.

On Key

Related Posts